Siemens Healthineers to Acquire Varian Medical Systems

Teledyne Technologies Acquires Varex Imaging in an ~$1.1B All-Cash Deal

August 10, 2026

Medical Devices

Teledyne Technologies Incorporated entered into a definitive agreement to acquire Varex Imaging Corporation for $18.90 per share in cash. The transaction is valued at approximately $1.1 billion (including Varex equity awards and net debt) and is expected to close in early 2027, subject to regulatory approvals and Varex stockholder approval.

Siemens Industry Software Acquires Altair Engineering

March 26, 2025

AI & Machine Learning

Siemens has signed an agreement to acquire Altair Engineering Inc. for $113 per share in cash, valuing the deal at about USD 10 billion. The transaction will combine Altair’s simulation, HPC, data science and AI capabilities with Siemens Xcelerator to create a more comprehensive AI-powered industrial software and digital twin portfolio.

HEALWELL AI to Acquire VeroSource Solutions

June 11, 2024

Healthcare Services

HEALWELL AI Inc. has agreed to acquire VeroSource Solutions Inc. for total consideration of approximately $24.5 million in a two-step transaction (initial ~51% on July 1, 2024 and remaining ~49% expected about January 1, 2025), payable in cash, HEALWELL subordinate voting shares and a performance-based earn-out. VeroSource, a Canadian health-data interoperability and digital-front-door platform serving provincial health clients, is expected to generate over $8 million in 2024 with strong recurring revenue and margins and will expand HEALWELL's population-health and AI-driven capabilities.

Varian (Siemens Healthineers) Acquires Aspekt Solutions from L2 Capital

April 30, 2024

Healthcare Services

Varian, a Siemens Healthineers company, has acquired Aspekt Solutions, a provider of medical physics, dosimetry and radiation oncology consulting and staffing services. The seller was L2 Capital, which realized its 2017 investment in the business; terms were not disclosed. The acquisition expands Varian's Advanced Oncology Solutions offerings and its ability to deliver customized clinical and operational support to oncology providers.

Novartis to Acquire MorphoSys in $2.9 Billion Deal

February 7, 2024

Pharmaceuticals

Novartis agreed to a voluntary public takeover offer to acquire MorphoSys AG for €68 per share, valuing the deal at about €2.7 billion (reported as $2.9 billion). The acquisition is intended to expand and complement Novartis’ oncology pipeline, including pelabresib (CPI-0610) and tulmimetostat (CPI-0209).

Varian Medical Systems to Acquire Cancer Treatment Services International from TPG Growth

May 20, 2019

Healthcare Services

Varian Medical Systems has signed a definitive agreement to acquire Cancer Treatment Services International (CTSI) from TPG Growth / Asia Healthcare Holdings for $283 million. CTSI operates a network of oncology hospitals, diagnostic and treatment services across India and South Asia (including the American Oncology Institute and AmPath), employs more than 1,500 people, and the deal is expected to close in roughly two weeks subject to customary conditions.